About Insignis Therapeutics
Insignis Therapeutics is a private company based in North Haven, Connecticut. It has reported $6,499,714 raised in two offerings on Form D since June 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Aug 5, 2026 | $5,999,714of $8.5M target | 4 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2023 | Jun 16, 2023 | $500,000target not set | 1 | $500K | EquityRule 506(c) | Form D ↗ |
| Total, two offerings | $6,499,714 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Insignis Therapeutics's Form D filed Aug 5, 2026.
MZ